Jeffrey Straubel reports sales of QS shares

QuantumScape insider reported sales of Class A common stock.

Rhea-AI Filing Summary

QuantumScape insider reported sales of Class A common stock. Jeffrey B. Straubel reported multiple dispositions, including 130,065 shares sold on 12/19/2025 for $1,485,251.25, 27,106 shares sold on 12/19/2025 for $303,749.84, and 27,106 shares sold on 01/05/2026 for $305,690.63. The filings state the shares were acquired as Restricted Stock Units on 03/17/2011.

Insights

Insider Transactions Analyst

Insider sold multiple tranches totaling 184,277 shares across December 2025 and January 2026.

The filings list three reported dispositions: 130,065 shares on 12/19/2025 for $1,485,251.25, 27,106 shares on 12/19/2025 for $303,749.84, and 27,106 shares on 01/05/2026 for $305,690.63. The source shows the securities were acquired as Restricted Stock Units on 03/17/2011.

Cash‑flow treatment is reported as proceeds to the selling holder; timing and method of sale are the dates shown. Subsequent disclosures or transaction confirmations may provide venue or plan details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sales did Jeffrey B. Straubel report in the QS filing?

He reported three dispositions totaling 184,277 shares. The filing shows 130,065 shares on 12/19/2025 for $1,485,251.25, 27,106 shares on 12/19/2025 for $303,749.84, and 27,106 shares on 01/05/2026 for $305,690.63.

Were the QS shares sold by Straubel originally restricted stock units?

Yes. The filing states the shares were acquired as Restricted Stock Units on 03/17/2011. The entry lists the acquisition date and describes the source as compensation via RSUs.

Who received the proceeds from the QS sales reported in the filing?

The filing indicates proceeds were received by the selling holder, Jeffrey B. Straubel. Dollar amounts for each reported sale are provided alongside the share counts and dates.

What dates are shown for the reported QS transactions?

Reported disposition dates are 12/19/2025 and 01/05/2026. The RSU acquisition date is shown as 03/17/2011 in the filing.

Does the filing state the method or venue of the QS share sales?

The excerpt lists sale dates, share counts, and gross proceeds but does not describe the specific trading venue or method. Additional transaction details may appear in related confirmations or subsequent filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001494727
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	QuantumScape Corporation
SEC File Number	001-39345
Address of Issuer	1730 Technology Drive San Jose CALIFORNIA 95110
Phone	1-408-452-2000
Name of Person for Whose Account the Securities are To Be Sold	Jeffrey B. Straubel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	27106	194350.02	562404592	02/19/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	03/17/2011	Acquired as compensation -- Restricted Stock Units	The Issuer			27106	03/17/2011	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeffrey B. Straubel 1730 Technology Drive San Jose CA 95110	Class A Common Stock	01/05/2026	27106	305690.63
Jeffrey B. Straubel 1730 Technology Drive San Jose CA 95110	Class A Common Stock	12/19/2025	130065	1485251.25
Jeffrey B. Straubel 1730 Technology Drive San Jose CA 95110	Class A Common Stock	12/19/2025	27106	303749.84

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 6/13/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Jeffrey B. Straubel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)